The Department of Health and Human Services, Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to the German non-profit organization Deutsche Diabetes Forschungsgesellschaft E.V. for a $146,715.00 diabetes research project. The contract, which had no set-aside designation, funds mathematical modeling and analysis services to forecast diabetes prevalence and assess the impact of risk factors, including the effect of the COVID-19 pandemic. This award is part of...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $220,266.39 firm fixed price purchase order contract to Deutsche Diabetes Forschungsgesellschaft E.V, a German non-profit organization, to conduct a diabetes study within U.S. adults. The contract, which does not have a set-aside designation, funds mathematical modeling and risk score analysis to forecast diabetes prevalence and assess the impact of various risk factors, including the...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the prevalence of late diabetes in Pima Indians in the United States. The contract is a firm fixed-price purchase order with a potential value of $147,876.39 and a completion date of September 29, 2018. Deutsche Diabetes...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract, valued at $196,324.31, is for the application of compartment models to forecast diabetes prevalence and assess the impact of various risk factors, including the effect of the COVID-19 pandemic. The contract has a period of performance ending on...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the impact of changes in diabetes risk score components on future diabetes prevalence. The $178,519.19 contract, awarded on August 6, 2021, does not have a set-aside designation and is scheduled to conclude on August 31,...
This is a $147,470.09 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Baker Heart and Diabetes Institute, a non-profit medical research facility based in Australia. The contract was for research on global and country-specific trends in the incidence of Type 2 diabetes. The contract did not have a set-aside designation. The Baker Heart and Diabetes Institute has previously performed research services as a subcontractor on federal...
This $149,893.46 firm fixed-price purchase order contract was awarded by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention to the Baker Heart and Diabetes Institute, a non-profit research organization, to conduct research on trends in the incidence of young onset Type 2 diabetes. The contract, which did not have a set-aside designation, was completed in February 2019. In addition to this prime contract, Baker Institute has also frequently served as a...
This federal contract award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) was made to the Baker Heart And Diabetes Institute, doing business as Baker Institute, a non-profit medical research organization. The $119,000.00 fixed-price purchase order was for research on trends in the incidence of young onset Type 2 diabetes, with a completion date of August 1, 2022. The contract did not utilize a set-aside designation. While Baker Institute has...
This is a $2,495,629.45 firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Deloitte Consulting LLP, a leading management and technology consulting firm, to identify and evaluate innovative strategies for retaining participants in the National Diabetes Prevention Program. The contract has an ultimate completion date of August 21, 2025. Deloitte has extensive experience supporting federal civilian agencies, including the CDC, through prime...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $22,750 firm fixed price purchase order to Dr. Céline Vetter of Almanya. The one-year contract runs from September 4, 2023 through September 3, 2024 to support the agency's research efforts. As the prime contractor, Dr. Vetter will deliver unspecified products or services to NIH/NIDDK to advance their diabetes, digestive, and kidney disease...